MedPath

Clinical and Genetic Analyzes of Age-related Macular Degeneration

Recruiting
Conditions
Macular Degeneration
Interventions
Genetic: Sampling
Registration Number
NCT03614481
Lead Sponsor
Centre Hospitalier Intercommunal Creteil
Brief Summary

The purpose of this collection is to search for susceptibility genes for age-related macular degeneration (AMD) alone or in combination with environmental factors and to look for genes that modulate the AMD phenotype (particularly the response to treatment).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
6000
Inclusion Criteria
  • Age> 55 years
  • Diagnosis of exudative or atrophic AMD in at least one eye
  • Patient informed of the objectives of the study and having freely signed the informed consent letter
  • Patient affiliated to a social security scheme
Exclusion Criteria
  • Other retinal or choroidal lesion in the studied eye
  • History of severe systemic disease that could potentially hinder patient adherence to the study protocol: mental disorder, cancer, recent stroke or heart failure less than 3 months old.
  • Known allergy to fluorescein, indocyanine green, iodine or ranibizumab

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control without AMDSampling898/5000 Given the observation of a mutation in an unaffected control individual, it is not excluded that this individual may be suffering from AMD at a later age. The observation of the mutation could thus be considered as a pre-clinical test. None of the teams were able to obtain a control population of the same age and sex ratio, which could have benefited from fluorescein angiography or at least a fundus examination, to ensure the absence of warning signs of AMD. This requires cooperation from healthy elderly volunteers not only for blood sampling but also for pupillary dilatation. The controls may be the accompanying persons or spouses of AMD patients. It may also be people seen in general consultation without maculopathy or retinopathy with an age greater than 55 years.
AMD patientSamplingDuring the AMD consultation, patients have their imaging exams including OCT, retinophotography, and fluorescein angiography. After the interview with the doctor on pathology diagnosis and follow-up, they will meet the clinical research associate nurse to complete the questionnaire and perform anthropometric measurements (weight, height, abdominal perimeter measurement and blood pressure measurement). Patients recruited at Créteil will benefit from a venous blood sample (20 mL) in 2 EDTA tubes for DNA extraction after light reading and signature of consent. For patients recruited from other ophthalmic centers, the Clinical Research Associate will perform salivary sampling for DNA extraction after light reading and signature of consent.
Primary Outcome Measures
NameTimeMethod
Genotypic factors6 months

Identification of genotypic factors associated with good or poor response to treatment in precisely phenotyped AMD patients.

Secondary Outcome Measures
NameTimeMethod
Environmental factors6 months

Look for predictive markers of treatment response among environmental factors

Circulating biological factors6 months

Identification of circulating biological factors such as circulating fatty acids at risk of AMD or modulating the response to treatment.

Predictive markers6 months

Look for predictive markers of cure response among polymorphisms that are susceptibility factors for AMD

Predictive treatment response score6 months

Create a predictive treatment response score that combines factors independently associated with the response to treatment in multivariate analysis

Vascular Endothelial Growth Factor6 months

Look for predictors of treatment response among polymorphisms of other genes: Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor

Trial Locations

Locations (5)

Hôpital général de Dijon

🇫🇷

Dijon, France

Hôpital Pellegrin

🇫🇷

Bordeaux, France

CHI Créteil

🇫🇷

Créteil, France

Hôpital des Quinze-Vingts

🇫🇷

Paris, France

Centre ophtalmologique d'imagerie et de laser

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath